Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.75 |
| ▸ | POLB | P06746 | 1/20 | 0.75 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.66 |
| ▸ | CA3 | P07451 | 2/20 | 0.64 |
| ▸ | CA5A | P35218 | 2/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.64 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | CA4 | P22748 | 1/20 | 0.64 |
| ▸ | CA6 | P23280 | 1/20 | 0.64 |
| ▸ | CA7 | P43166 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19781069 | 1.00 | MEN1 (0.79) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| Hydrochloric Acid SCHEMBL28974271 | 0.98 | MEN1 (0.76) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL6490885 | 0.98 | ALDH1A1 (0.78) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| Hydrochloric Acid SCHEMBL29241679 | 0.96 | SMN1; SMN2 (0.75) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| Trifluoroacetic Acid SCHEMBL30387588 | 0.94 | MEN1 (0.70) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL3149189 | 0.91 | ALDH1A1 (0.74) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL11981741 | 0.90 | CA5A (0.81) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| Hydrochloric Acid SCHEMBL29241548 | 0.89 | SMN1; SMN2 (0.71) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL29982917 | 0.89 | MEN1 (1.00) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL27889238 | 0.87 | ALDH1A1 (1.00) | MEN1KMT2AALDH1A1SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2914607-B1 | PHOTOCLEAVABLE LINKER MOLECULES WITH DIARYLSULPHID BACKBONE FOR TRANSIENT BIOCONJUGATE SYNTHESIS | VENTANA MED SYST INC (US) | 2017-11-29 | — | — | EP | disclosed |
| US-9790243-B2 | Photocleavable linker molecules with diarylsulphide backbone for transient bioconjugate synthesis | VENTANA MEDICAL SYSTEMS, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-20150284415-A1 | PHOTOCLEAVABLE LINKER MOLECULES WITH DIARYLSULPHID BACKBONE FOR TRANSIENT BIOCONJUGATE SYNTHESIS | VENTANA MED SYST INC (US) | 2015-10-08 | — | — | US | disclosed |
| EP-2914607-A1 | PHOTOCLEAVABLE LINKER MOLECULES WITH DIARYLSULPHID BACKBONE FOR TRANSIENT BIOCONJUGATE SYNTHESIS | Ventana Medical Systems, Inc. (US) | 2015-09-09 | — | — | EP | disclosed |
| WO-2014053397-A1 | PHOTOCLEAVABLE LINKER MOLECULES WITH DIARYLSULPHID BACKBONE FOR TRANSIENT BIOCONJUGATE SYNTHESIS | ROCHE DIAGNOSTICS GMBH (DE) | 2014-04-10 | — | — | WO | disclosed |
| US-8680062-B2 | System for delivering therapeutic agents into living cells and cells nuclei | Deliversir Ltd. (IL) | 2014-03-25 | — | — | US | disclosed |
| US-8680062-B2 | System for delivering therapeutic agents into living cells and cells nuclei | Deliversir Ltd. (IL) | 2014-03-25 | — | — | US | disclosed |
| US-20080004234-A1 | System for delivering therapeutic agents into living cells and cells nuclei | SEGEV LABORATORIES LIMITED (IL) | 2008-01-03 | — | — | US | disclosed |
| US-20080004234-A1 | System for delivering therapeutic agents into living cells and cells nuclei | SEGEV LABORATORIES LIMITED (IL) | 2008-01-03 | — | — | US | disclosed |
| US-7223833-B1 | Peptide nucleic acid conjugates | ISIS PHARMACEUTICALS, INC. (US) | 2007-05-29 | — | — | US | disclosed |
| WO-1996011205-A1 | PEPTIDE NUCLEIC ACID CONJUGATES | ISIS PHARMACEUTICALS, INC. (US) | 1996-04-18 | — | — | WO | disclosed |
| US-5156840-A | Covalently attached to an antibody | CYTOGEN CORPORATION (US) | 1992-10-20 | — | — | US | disclosed |
| EP-0088695-B1 | ANTIBODY CONJUGATES | CYTOGEN CORPORATION (US) | 1992-06-03 | — | — | EP | disclosed |
| EP-0175617-B1 | ANTIBODY-THERAPEUTIC AGENT CONJUGATES | CYTOGEN CORPORATION (US) | 1991-10-30 | — | — | EP | disclosed |
| US-4867973-A | DRUG DELIVERY | CYTOGEN CORPORATION (US) | 1989-09-19 | — | — | US | disclosed |
| WO-1986001720-A1 | ANTIBODY THERAPEUTIC AGENT CONJUGATES | CYTOGEN CORPORATION (US) | 1986-03-27 | — | — | WO | disclosed |
| EP-0175617-A2 | Antibody-therapeutic agent conjugates | CYTOGEN CORPORATION (US) | 1986-03-26 | — | — | EP | disclosed |
| EP-0088695-A2 | Antibody conjugates | CYTOGEN CORPORATION (US) | 1983-09-14 | — | — | EP | disclosed |
| US-4243605-A | RADIOIMMUNOASSAY, LABELS | UNION CARBIDE CORPORATION (US) | 1981-01-06 | — | — | US | disclosed |
| US-4115539-A | RADIOIMMUNOASSAY, REACTION PRODUCT WITH ISOCYANATES | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284415-A1 | PHOTOCLEAVABLE LINKER MOLECULES WITH DIARYLSULPHID BACKBONE FOR TRANSIENT BIOCONJUGATE SYNTHESIS | DHFR, DTYMK, DNPEP | MEN1 2927/4885KMT2A 1482/4885ALDH1A1 2382/4885 |
| US-20080004234-A1 | System for delivering therapeutic agents into living cells and cells nuclei | RCC1, NUMA1, ACIN1 | MEN1 1982/4885KMT2A 4420/4885ALDH1A1 3923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.